SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001171843-20-003601
Filing Date
2020-05-11
Accepted
2020-05-11 17:23:16
Documents
47
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q f10q_051120p.htm 10-Q 325707
2 EXHIBIT 31.1 exh_311.htm EX-31.1 7939
3 EXHIBIT 31.2 exh_312.htm EX-31.2 7922
4 EXHIBIT 32.1 exh_321.htm EX-32.1 4950
  Complete submission text file 0001171843-20-003601.txt   2546391

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE xbit-20200331.xml EX-101.INS 352483
6 XBRL SCHEMA FILE xbit-20200331.xsd EX-101.SCH 30748
7 XBRL CALCULATION FILE xbit-20200331_cal.xml EX-101.CAL 28111
8 XBRL DEFINITION FILE xbit-20200331_def.xml EX-101.DEF 250569
9 XBRL LABEL FILE xbit-20200331_lab.xml EX-101.LAB 207463
10 XBRL PRESENTATION FILE xbit-20200331_pre.xml EX-101.PRE 265811
Mailing Address 8201 E. RIVERSIDE DRIVE BUILDING 4, SUITE 100 AUSTIN TX 78744
Business Address 8201 E. RIVERSIDE DRIVE BUILDING 4, SUITE 100 AUSTIN TX 78744 512-386-2930
XBiotech Inc. (Filer) CIK: 0001626878 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37347 | Film No.: 20866121
SIC: 2834 Pharmaceutical Preparations